Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High viral SARS-CoV-2 load in placenta of patients with hypertensive disorders after COVID-19 during pregnancy

M Fabre, P Calvo, S Ruiz-Martinez, M Peran, D Oros, A Medel Martinez, M Strunk, R Benito, J Schoorlemmer, C Paules
doi: https://doi.org/10.1101/2021.09.07.21261607
M Fabre
aInstituto de Investigación Sanitario de Aragón (IIS Aragon) Biochemistry Department, Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain
bPlacental pathophysiology & fetal programming research group, B46_20R & GIIS-028 del IISA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Calvo
bPlacental pathophysiology & fetal programming research group, B46_20R & GIIS-028 del IISA
cInstituto de Investigación Sanitario de Aragón (IIS Aragon), Obstetrics Department, Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Ruiz-Martinez
bPlacental pathophysiology & fetal programming research group, B46_20R & GIIS-028 del IISA
cInstituto de Investigación Sanitario de Aragón (IIS Aragon), Obstetrics Department, Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain
dRed de Salud Materno Infantil y del Desarrollo (SAMID), RETICS. Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación y Fomento de la Investigación y Fondo Europeo de Desarrollo Regional (FEDER) Ref: RD16/0022/0013
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Peran
aInstituto de Investigación Sanitario de Aragón (IIS Aragon) Biochemistry Department, Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain
bPlacental pathophysiology & fetal programming research group, B46_20R & GIIS-028 del IISA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Oros
bPlacental pathophysiology & fetal programming research group, B46_20R & GIIS-028 del IISA
cInstituto de Investigación Sanitario de Aragón (IIS Aragon), Obstetrics Department, Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain
dRed de Salud Materno Infantil y del Desarrollo (SAMID), RETICS. Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación y Fomento de la Investigación y Fondo Europeo de Desarrollo Regional (FEDER) Ref: RD16/0022/0013
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Medel Martinez
eLaboratorio Satélite, Instituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), Zaragoza, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Strunk
eLaboratorio Satélite, Instituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), Zaragoza, Spain
fSequencing and Functional Genomics, Instituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), Zaragoza, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Benito
gMicrobiology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. Universidad de Zaragoza. IIS Aragon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Schoorlemmer
bPlacental pathophysiology & fetal programming research group, B46_20R & GIIS-028 del IISA
hInstituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain
iARAID Foundation, Zaragoza, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jonas@araid.es
C Paules
bPlacental pathophysiology & fetal programming research group, B46_20R & GIIS-028 del IISA
cInstituto de Investigación Sanitario de Aragón (IIS Aragon), Obstetrics Department, Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain
dRed de Salud Materno Infantil y del Desarrollo (SAMID), RETICS. Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación y Fomento de la Investigación y Fondo Europeo de Desarrollo Regional (FEDER) Ref: RD16/0022/0013
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Studies described an increased frequency of hypertensive disorders of pregnancy after a COVID-19 episode. There is limited evidence about SARS-CoV-2 viral load in placenta. This study aimed to investigate the relationship between SARS-CoV-2 viral load in placenta and clinical development of HDP after COVID-19 throughout different periods of gestation.

Methods This was a case-control study in women with and without gestational hypertensive disorders (HDP) after SARS-CoV-2 infection diagnosed by RT-PCR during pregnancy. Patients were matched by gestational age at the moment of COVID-19 diagnosis. We performed an analysis of SARS-CoV-2 RNA levels in placenta.

Results A total of 28 women were enrolled. Sixteen patients were diagnosed with COVID-19 during the third trimester and the remaining twelve patients in the others trimesters. Ten placentas (35.7%) were positive for SARS-CoV-2, nine of them (90%) belonged to the HDP group versus one (10%) in control group (p=0.009). Those cases with the highest loads of viral RNA developed severe-preeclampsia.

Conclusion The presence of SARS-CoV-2 was more frequent in placentas of patients with HDP after COVID-19. There seems to be a relationship between high viral load in the placenta and the development of hypertensive disorders. We found SARS-CoV-2 viral load in placenta after birth in mothers infected at the first half of pregnancy, but with negative nasopharyngeal RT-PCR at delivery. Our data suggest that SARS-CoV-2 infection during pregnancy could trigger gestational hypertensive disorders through placenta-related mechanisms.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Part of the work has been financed by research grant FIS PI17/02208 from the Instituto de Salud Carlos III to Jon Schoorlemmer. The work described in this manuscript has been financed by grants from the Government of Aragon, cofinanced by FEDER ("Una manera de hacer Europa, Construyendo Europa desde Aragon"/European Social Funds): B05_17D. The funding bodies played no role in the design of the study, in the collection, analysis, and interpretation of data, in writing the manuscript and in the decision to submit the article for publication. P Calvo, M Fabre, C Paules, D Oros and S Ruiz-Martinez were supported by a research grant from the Instituto de Salud Carlos III (CM20/00078, FI20/00071, JR19/00006, INT20/00033 and CM18/00202).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

. The study was approved by the Research Ethics Committee of the Community of Aragon (C.I. PI21/155 and COL21/000).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data generated or analyzed during this study are included in this article and its supplementary material files. Further enquiries can be directed to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High viral SARS-CoV-2 load in placenta of patients with hypertensive disorders after COVID-19 during pregnancy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High viral SARS-CoV-2 load in placenta of patients with hypertensive disorders after COVID-19 during pregnancy
M Fabre, P Calvo, S Ruiz-Martinez, M Peran, D Oros, A Medel Martinez, M Strunk, R Benito, J Schoorlemmer, C Paules
medRxiv 2021.09.07.21261607; doi: https://doi.org/10.1101/2021.09.07.21261607
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
High viral SARS-CoV-2 load in placenta of patients with hypertensive disorders after COVID-19 during pregnancy
M Fabre, P Calvo, S Ruiz-Martinez, M Peran, D Oros, A Medel Martinez, M Strunk, R Benito, J Schoorlemmer, C Paules
medRxiv 2021.09.07.21261607; doi: https://doi.org/10.1101/2021.09.07.21261607

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1244)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (532)
  • Epidemiology (10027)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2462)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1645)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (250)
  • HIV/AIDS (535)
  • Infectious Diseases (except HIV/AIDS) (11871)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2289)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1248)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (733)
  • Pharmacology and Therapeutics (314)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4840)
  • Radiology and Imaging (838)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (286)
  • Sexual and Reproductive Health (240)
  • Sports Medicine (227)
  • Surgery (268)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)